Sexually transmitted diseases and infertility

American Journal of Obstetrics and Gynecology

Volumn 216, Issue 1, 2017, Pages 1-9

  Tsevat, Danielle G ^a   Wiesenfeld, Harold C ^b   Parks, Caitlin ^a   Peipert, Jeffrey F ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chlamydia; gonorrhea; infertility; STD; STI

Indexed keywords

BIBLIOGRAPHIC DATABASE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; GONORRHEA; HUMAN; IMMUNE RESPONSE; MIXED INFECTION; MORBIDITY; MYCOPLASMA GENITALIUM; MYCOPLASMOSIS; NEISSERIA GONORRHOEAE; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; URETHRITIS; UTERINE TUBE OCCLUSION; CHLAMYDIA INFECTIONS; INFERTILITY, FEMALE; MYCOPLASMA INFECTIONS; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS VAGINITIS;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; INFERTILITY, FEMALE; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; NEISSERIA GONORRHOEAE; PELVIC INFLAMMATORY DISEASE; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS;

EID: 85006698862     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.08.008     Document Type: Review

References (119)

1. 1 Boivin, J., Bunting, L., Collins, J.A., Nygren, K.G., International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 22 (2007), 1506–1512.
2. 2 Chandra, A., Copen, C.E., Stephen, E.H., Infertility and impaired fecundity in the United States, 1982–2010: data from the National Survey of Family Growth. Natl Health Stat Rep 67 (2013), 1–19.
3. 3 Inhorn, M., Patrizio, P., Infertility around the globe: new thinking on gender, reproductive technologies, and global movement in the 21st century. Hum Reprod Update 21 (2015), 411–426.
4. 4 Cousineau, T.M.D., Alice, D., Psychological impact of infertility. Clin Obstet Gynecol 21 (2006), 293–308.
5. 5 Ezeh, A., Bankole, A., Cleland, J., García-Moreno, C., Temmerman, M., Ziraba, A.K., Burden of reproductive ill health., 3rd ed. Black, R.E., Laxminarayan, R., Temmerman, M., Walker, N., (eds.) Reproductive, maternal, newborn, and child health: disease control priorities, Vol 2, 2016, International Bank for Reconstruction and Development/World Bank, Washington (DC).
6. 6 Daar A, Merali Z. World Health Organization; [June 8, 2009]. Infertility and social suffering: the case of ART in developing countries. Available at: http://www.who.int/reproductive-health/infertility/5.pdf.
7. 7 Quaas, A., Dokras, A., Diagnosis and treatment of unexplained infertility. Rev Obstet Gynecol 1 (2008), 69–76.
8. 8 Centers for Disease Control and Prevention 2006. 2004 Assisted reproductive technology success rates: National Summary and Fertility Clinic Reports. http://ftp.cdc.gov/pub/publications/art/2004ART508.pdf.
9. 9 Wiesenfeld, H.C., Cates, W., Sexually transmitted diseases and infertility. Holmes KK SP, Stamm, W.E., Piot, P., et al. (eds.) Sexually transmitted diseases, 4th ed., 2008, McGraw Hill, New York, 1511–1529.
10. 10 Khanum, S., Ahmed, J., Rahim, M., Sultana, N., Begum, R., Evidence-based diagnostic approach to tubal factor infertility. Birdem Med J 4 (2014), 33–37.
11. 11 Schuchardt L, Rupp J. Chlamydia trachomatis as the cause of infectious infertility: acute, repetitive, or persistent long-term infection? In: Curr Top Microbiol Immunol. 2 Jul 2016; [Epub ahead of print].
12. 12 Westrom, L., Effect of pelvic inflammatory disease on fertility. Venereology 8 (1995), 219–222.
13. 13 Wiesenfeld, H.C., Hillier, S.L., Meyn, L.A., Amortegui, A.J., Sweet, R.L., Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol 120 (2012), 37–43.
14. 14 Noeggerath, E., Latent gonorrhea, especially with regard to its influence on fertility in women. Trans Am Gynaecol Assoc, 1, 1876, 292.
15. 15 Cates, W., Rolfs, R.T., Aral, S.O., Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev 12 (1990), 199–220.
16. 16 Bowen, E., Limits of the lab: diagnosing “latent gonorrhea,” 1872-1910. Bull Hist Med 87 (2013), 63–85.
17. 17 Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2008. 2009, US Department of Health and Human Services, Atlanta (GA).
18. 18 Nelson, H.D., Zakher, B., Cantor, A., Deagas, M., Pappas, M., Screening for gonorrhea and chlamydia: systematic review to update the US Preventive Services Task Force Recommendations. 2014, Agency for Healthcare Research and Quality, Rockville, MD.
19. 19 Papp, J.R., Schachter, J., Gaydos, C.A., Van Der Pol, B., Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae–2014. MMWR Recomm Rep, 63, 2014, 1.
20. 20 Linhares, I.M., Witkin, S.S., Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract. Cell Stress Chaperones 15 (2010), 467–473.
21. 21 Mårdh, P.-A., Tubal factor infertility, with special regard to chlamydial salpingitis. Curr Opin Infect Dis 17 (2004), 49–52.
22. 22 Akande, V.A., Hunt, L.P., Cahill, D.J., Caul, E.O., Ford, W.C.L., Jenkins, J.M., Tubal damage in infertile women: prediction using Chlamydia serology. Hum Reprod 18 (2003), 1841–1847.
23. 23 Clausen, H.F., Fedder, J., Drasbek, M., et al. Serological investigation of Mycoplasma genitalium in infertile women. Hum Reprod 16 (2001), 1866–1874.
24. 24 Svenstrup, H.F., Fedder, J., Kristoffersen, S.E., Trolle, B., Birkelund, S., Christiansen, G., Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility–a prospective study. Fertil Steril 90 (2008), 513–520.
25. 25 Veenemans, L., Van der Linden, P., The value of Chlamydia trachomatis antibody testing in predicting tubal factor infertility. Hum Reprod 17 (2002), 695–698.
26. 26 Meikle, S., Zhang, X., Marine, W., Calonge, B., Hamman, R., Betz, G., Chlamydia trachomatis antibody titers and hysterosalpingography in predicting tubal disease in infertility patients. Fertil Steril 62 (1994), 305–312.
27. 27 Den Hartog, J., Land, J., Stassen, F., Kessels, A., Bruggeman, C., Serological markers of persistent C trachomatis infections in women with tubal factor subfertility. Hum Reprod 20 (2005), 986–990.
28. 28 Coppus, S., Land, J., Opmeer, B., et al. Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology. Hum Reprod 26 (2011), 3061–3067.
29. 29 Thomas, K., Coughlin, L., Mannion, P., Haddad, N., The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations. Hum Reprod 15 (2000), 1079–1082.
30. 30 Weström, L., Pelvic inflammatory disease: bacteriology and sequelae. Contraception 36 (1987), 111–128.
31. 31 Mol, B., Lijmer, J.G., Ankum, W.M., van der Veen, F., Bossuyt, P., The accuracy of single serum progesterone measurement in the diagnosis of ectopic pregnancy: a meta-analysis. Hum Reprod 13 (1998), 3220–3227.
32. 32 Cates, W., Wasserheit, J.N., Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 164 (1991), 1771–1781.
33. 33 Haggerty, C.L., Gottlieb, S.L., Taylor, B.D., Low, N., Xu, F., Ness, R.B., Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 201:Suppl (2010), S134–S155.
34. 34 Westrom, L., Joesoef, R., Reynolds, G., Hagdu, A., Thompson, S.E., Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 19 (1992), 185–192.
35. 35 Wiesenfeld, H.C., Sweet, R.L., Ness, R.B., Krohn, M.A., Amortegui, A.J., Hillier, S.L., Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 32 (2005), 400–405.
36. 36 Mol, B.W., Dijkman, B., Wertheim, P., Lijmer, J., van der Veen, F., Bossuyt, P.M., The accuracy of serum chlamydial antibodies in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril 67 (1997), 1031–1037.
37. 37 Geisler, W.M., Morrison, S.G., Doemland, M.L., et al. Immunoglobulin-specific responses to Chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection. J Infect Dis 206 (2012), 1836–1843.
38. 38 Feinberg, E.C., Expanding the scope of the basic infertility workup. Fertil Steril, 104, 2015, 1379.
39. 39 Steiner, A.Z., Diamond, M.P., Legro, R.S., et al. Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes. Fertil Steril 104 (2015), 1522–1526.
40. 40 Collins, A.M., Jackson, K.J., A temporal model of human IgE and IgG antibody function. Front Immunol, 4, 2013, 235.
41. 41 Neuer, A., Spandorfer, S.D., Giraldo, P., Dieterle, S., Rosenwaks, Z., Witkin, S.S., The role of heat shock proteins in reproduction. Hum Reprod Update 6 (2000), 149–159.
42. 42 Stephens, A.J., Aubuchon, M., Schust, D.J., Antichlamydial antibodies, human fertility, and pregnancy wastage. Infect Dis Obstet Gynecol, 2011, 2011, 525182.
43. 43 Swasdio, K., Rugpao, S., Tansathit, T., et al. The association of Chlamydia trachomatis/gonococcal infection and tubal factor infertility. J Obstet Gynaecol Res 22 (1996), 331–340.
44. 44 Grodstein, F., Goldman, M.B., Cramer, D.W., Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol 137 (1993), 577–584.
45. 45 Robertson, J., Ward, M., Conway, D., Caul, E., Chlamydial and gonococcal antibodies in sera of infertile women with tubal obstruction. J Clin Pathol 40 (1987), 377–383.
46. 46 Miettinen, A., Heinonen, P.K., Teisala, K., Hakkarainen, K., Punnonen, R., Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy. Sex Transm Dis, 17, 1990, 10.
47. 47 World Health Organization. Task force on the prevention and management of infertility. Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. Sex Transm Dis 22 (1995), 71–77.
48. 48 Hillis, S.D., Joesoef, R., Marchbanks, P.A., Wasserheit, J.N., Cates, W., Westrom, L., Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 168 (1993), 1503–1509.
49. 49 Paavonen, J., Eggert-Kruse, W., Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 5 (1999), 433–447.
50. 50 Short, V.L., Totten, P.A., Ness, R.B., Astete, S.G., Kelsey, S.F., Haggerty, C.L., Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis 48 (2009), 41–47.
51. 51 Moore, M.S., Golden, M.R., Scholes, D., Kerani, R.P., Assessing trends in Chlamydia positivity and gonorrhea incidence and their associations with the incidence of pelvic inflammatory disease and ectopic pregnancy in Washington state, 1988-2010. Sex Transm Dis 43 (2016), 2–8.
52. 52 Manhart, L.E., Holmes, K.K., Hughes, J.P., Houston, L.S., Totten, P.A., Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health, 97, 2007, 1118.
53. 53 Haggerty, C.L., Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis 21 (2008), 65–69.
54. 54 Palmer, H.M., Gilroy, C.B., Furr, P.M., Taylor-Robinson, D., Development and evaluation of the polymerase chain reaction to detect Mycoplasma genitalium. FEMS Microbiol Lett 61 (1991), 199–203.
55. 55 Huppert, J.S., Mortensen, J.E., Reed, J.L., Kahn, J.A., Rich, K.D., Hobbs, M.M., Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis 35 (2008), 250–254.
56. 56 Fraser, C.M., Gocayne, J.D., White, O., et al. The minimal gene complement of Mycoplasma genitalium. Science 270 (1995), 397–404.
57. 57 Tully, J., Cole, R., Taylor-Robinson, D., Rose, D., A newly discovered mycoplasma in the human urogenital tract. Lancet 317 (1981), 1288–1291.
58. 58 Manhart, L., Broad, J., Golden, M., Mycoplasma genitalium: should we treat and how?. Clin Infect Dis 53 (2011), S129–S142.
59. 59 Idahl, A., Jurstrand, M., Olofsson, J.I., Fredlund, H., Mycoplasma genitalium serum antibodies in infertile couples and fertile women. Sex Transm Infect 10 (2015), 1–3.
60. 60 Møller, B., Taylor-Robinson, D., Furr, P.M., Toft, B., Allen, J., Serological evidence that chlamydiae and mycoplasmas are involved in infertility of women. J Reprod Fertil 73 (1985), 237–240.
61. 61 Grześko, J., Elias, M., Mączyńska, B., Kasprzykowska, U., Tłaczała, M., Goluda, M., Occurrence of Mycoplasma genitalium in fertile and infertile women. Fertil Steril 91 (2009), 2376–2380.
62. 62 McGowin, C.L., Ma, L., Martin, D.H., Pyles, R.B., Mycoplasma genitalium-encoded MG309 activates NF-κB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells. Infect Immun 77 (2009), 1175–1181.
63. 63 McGowin, C.L., Popov, V.L., Pyles, R.B., Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing. BMC Microbiol, 9, 2009, 139.
64. 64 Baczynska, A., Funch, P., Fedder, J., Knudsen, H.J., Birkelund, S., Christiansen, G., Morphology of human fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis–in vitro organ culture study. Hum Reprod 22 (2007), 968–979.
65. 65 Svenstrup, H.F., Fedder, J., Abraham-Peskir, J., Birkelund, S., Christiansen, G., Mycoplasma genitalium attaches to human spermatozoa. Hum Reprod 18 (2003), 2103–2109.
66. 66 Ashshi, A.M., Batwa, S.A., Kutbi, S.Y., Malibary, F.A., Batwa, M., Refaat, B., Prevalence of 7 sexually transmitted organisms by multiplex real-time PCR in fallopian tube specimens collected from Saudi women with and without ectopic pregnancy. BMC Infect Dis, 15, 2015, 569.
67. 67 Møller, B., Taylor-Robinson, D., Furr, P., Freundt, E., Acute upper genital-tract disease in female monkeys provoked experimentally by Mycoplasma genitalium. Br J Exp Pathol, 66, 1985, 417.
68. 68 McGowin, C.L., Spagnuolo, R.A., Pyles, R.B., Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation. Infect Immun 78 (2010), 726–736.
69. 69 Jurstrand, M., Jensen, J.S., Magnuson, A., Kamwendo, F., Fredlund, H., A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy. Sex Transm Infect 83 (2007), 319–323.
70. 70 Møller, B., Taylor-Robinson, D., Purr, P., Serological evidence implicating Mycoplasma genitalium in pelvic inflammatory disease. Lancet 323 (1984), 1102–1103.
71. 71 Lind, K., Kristensen, G., Significance of antibodies to Mycoplasma genitalium in salpingitis. Eur J Clin Microbiol Infect Dis 6 (1987), 205–207.
72. 72 Haggerty, C.L., Totten, P.A., Astete, S.G., et al. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect 84 (2008), 338–342.
73. 73 Simms, I., Eastick, K., Mallinson, H., et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease. J Clin Pathol 56 (2003), 616–618.
74. 74 Bjartling, C., Osser, S., Persson, K., The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 117 (2010), 361–364.
75. 75 Cohen, C., Mugo, N., Astete, S., et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect 81 (2005), 463–466.
76. 76 Oakeshott, P., Aghaizu, A., Hay, P., et al. Is Mycoplasma genitalium in women the “new Chlamydia?” A community-based prospective cohort study. Clin Infect Dis 51 (2010), 1160–1166.
77. 77 Lis, R., Rowhani-Rahbar, A., Manhart, L.E., Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 61 (2015), 418–426.
78. 78 World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections. 2001, WHO, Geneva.
79. 79 Coleman, J.S., Gaydos, C.A., Witter, F., Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies. Obstet Gynecol Surv, 68, 2013, 43.
80. 80 Satterwhite, C.L., Torrone, E., Meites, E., et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 40 (2013), 187–193.
81. 81 Klinger, E.V., Kapiga, S.H., Sam, N.E., et al. A community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania. Sex Transm Dis 33 (2006), 712–718.
82. 82 Passey, M., Mgone, C., Lupiwa, S., et al. Community-based study of sexually transmitted diseases in rural women in the highlands of Papua New Guinea: prevalence and risk factors. Sex Transm Infect 74 (1998), 120–127.
83. 83 Sherman, K.J., Daling, J.R., Weiss, N.S., Sexually transmitted diseases and tubal infertility. Sex Transm Dis 14 (1987), 12–16.
84. 84 El-Shazly, A.M., El-Naggar, H.M., Soliman, M., et al. A study on Trichomonas vaginalis and female infertility. J Egypt Soc Parasitol 31 (2001), 545–553.
85. 85 Reighard, S.D., Sweet, R.L., Vicetti Miguel, C., et al. Endometrial leukocyte subpopulations associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis genital tract infection. Am J Obstet Gynecol 205 (2011), 324.e1–324.e7.
86. 86 Mårdh, P., Weström, L., Tubal and cervical cultures in acute salpingitis with special reference to Mycoplasma hominis and T-strain mycoplasmas. Br J Vener Dis 46 (1970), 179–186.
87. 87 Cherpes, T.L., Wiesenfeld, H.C., Melan, M.A., et al. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis 33 (2006), 747–752.
88. 88 Cates, W., Joesoef, M.R., Goldman, M.B., Atypical pelvic inflammatory disease: can we identify clinical predictors?. Am J Obstet Gynecol 169 (1993), 341–346.
89. 89 Hoosen, A., Quinlan, D., Moodley, J., Kharsany, A., Van den Ende, J., Sexually transmitted pathogens in acute pelvic inflammatory disease. S Afr Med J 76 (1989), 251–254.
90. 90 Moodley, P., Wilkinson, D., Connolly, C., Moodley, J., Sturm, A.W., Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 34 (2002), 519–522.
91. 91 Pindak, F., De Pindak, M.M., Hyde, B., Gardner, W., Acquisition and retention of viruses by Trichomonas vaginalis. Genitourin Med 65 (1989), 366–371.
92. 92 Scholtyseck, E., Teras, J., Kasakova, I., Sethi, K., Electron microscope observations on the interaction of Mycoplasma fermentans with Trichomonas vaginalis. Z Parasitenkd 71 (1985), 435–442.
93. 93 Francioli, P., Shio, H., Roberts, R.B., Müller, M., Phagocytosis and killing of Neisseria gonorrhoeae by Trichomonas vaginalis. J Infect Dis 147 (1983), 87–94.
94. 94 Hardy, P., Nell, E.E., Spence, M., Hardy, J., Graham, D., Rosenbaum, R., Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 324 (1984), 333–337.
95. 95 Mårdh, P., Weström, L., von Mecklenburg, C., Hammar, E., Studies on ciliated epithelia of the human genital tract. I: swelling of the cilia of fallopian tube epithelium in organ cultures infected with Mycoplasma hominis. Br J Vener Dis 52 (1976), 52–57.
96. 96 Mårdh, P., Weström, L., Antibodies to Mycoplasma hominis in patients with genital infections and in healthy controls. Br J Vener Dis 46 (1970), 390–397.
97. 97 Khan, J., Farzand, R., Prevalence of Mycoplasma hominis and Ureaplasma urealyticum among women with unexplained infertility, with and without vaginitis and cervicitis. Afr J Micobiol Res 5 (2011), 861–864.
98. 98 Sweet, R.L., Colonization of the endometrium and fallopian tubes with Ureaplasma urealyticum. Pediatr Infect Dis J 5 (1986), S244–S246.
99. 99 Baczynska, A., Svenstrup, H.F., Fedder, J., Birkelund, S., Christiansen, G., The use of enzyme-linked immunosorbent assay for detection of Mycoplasma hominis antibodies in infertile women serum samples. Hum Reprod 20 (2005), 1277–1285.
100. 100 Tyagi, P., Mycoplasmal antibodies as determined with an enzyme-linked immunosorbent assay, in tubal factor infertility. Ind J Med Sci, 53, 1999, 481.
101. 101 Totten, P.A., Taylor-Robinson, D., Jensen, J.S., Genital mycoplasmas. Holmes KK SP, Stamm, W.E., Piot, P., et al. (eds.) Sexually transmitted diseases, 4th ed., 2008, McGraw Hill, New York, 709–736.
102. 102 Eftekhar, M., Pourmasumi, S., Sabeti, P., Aflatoonian, A., Sheikhha, M.H., Mycobacterium tuberculosis infection in women with unexplained infertility. Int J Reprod Biomed (Yazd) 13 (2015), 749–754.
103. 103 Banerjee, A., Prateek, S., Malik, S., Dhingra, D., Genital tuberculosis in adolescent girls from low socioeconomic status with acute ectopic pregnancy presenting at a tertiary care hospital in urban Northern India: are we missing an opportunity to treat?. Arch Gynecol Obstet 286 (2012), 1477–1482.
104. 104 Sharma, J.B., Naha, M., Kumar, S., Roy, K.K., Singh, N., Arora, R., Genital tuberculosis: an important cause of ectopic pregnancy in India. Indian J Tuberc 61 (2014), 312–317.
105. 105 Al eryani, A.A., Abdelrub, A.S., Al Harazi, A.H., Genital tuberculosis is common among females with tubal factor infertility: observational study. Alexandria J Med 51 (2015), 321–324.
106. 106 Sharma, J.B., Sneha, J., Singh, J.B., et al. Comparative study of laparoscopic abdominopelvic and fallopian tube findings before and after antitubercular therapy in female genital tuberculosis with infertility. J Minim Invasive Gynecol 23 (2016), 215–222.
107. 107 Sirota, I., Zarek, S.M., Segars, J.H., Potential influence of the microbiome on infertility and assisted reproductive technology. Semin Reprod Med 32 (2014), 35–42.
108. 108 van Oostrum, N., De Sutter, P., Meys, J., Verstraelen, H., Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Hum Reprod 28 (2013), 1809–1815.
109. 109 Gaudoin, M., Rekha, P., Morris, A., Lynch, J., Acharya, U., Bacterial vaginosis and past chlamydial infection are strongly and independently associated with tubal infertility but do not affect in vitro fertilization success rates. Fertil Steril 72 (1999), 730–732.
110. 110 Liversedge, N.H., Turner, A., Horner, P.J., Keay, S.D., Jenkins, J.M., Hull, M.G., The influence of bacterial vaginosis on in-vitro fertilization and embryo implantation during assisted reproduction treatment. Hum Reprod 14 (1999), 2411–2415.
111. 111 Wilson, J.D., Ralph, S.G., Rutherford, A.J., Rates of bacterial vaginosis in women undergoing in vitro fertilization for different types of infertility. BJOG 109 (2002), 714–717.
112. 112 Durugbo, I., Nyengidiki, T., Bassey, G., Wariso, K., Bacterial vaginosis among women with tubal factor infertility in Nigeria. Int J Obstet Gynecol 131 (2015), 133–136.
113. 113 Hillier, S.L., Kiviat, N.B., Hawes, S.E., et al. Role of bacterial vaginosis–associated microorganisms in endometritis. Am J Obstet Gynecol 175 (1996), 435–441.
114. 114 Peipert, J.F., Montagno, A.B., Cooper, A.S., Sung, C.J., Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol 177 (1997), 1184–1187.
115. 115 Wiesenfeld, H.C., Hillier, S.L., Krohn, M.A., et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 100 (2002), 456–463.
116. 116 Mania-Pramanik, J., Kerkar, S., Salvi, V., Bacterial vaginosis: a cause of infertility?. Int J STD AIDS 20 (2009), 778–781.
117. 117 Soper, D.E., Brockwell, N.J., Dalton, H.P., Johnson, D., Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 170 (1994), 1008–1017.
118. 118 Taylor, B.D., Darville, T., Haggerty, C.L., Does bacterial vaginosis cause pelvic inflammatory disease?. Sex Transm Dis 40 (2013), 117–122.
119. 119 Meyers, D., Wolff, T., Gregory, K., et al. USPSTF recommendations for STI screening. Am Fam Physician 77 (2008), 819–824.